I have all the information needed. Now let me compile a comprehensive, well-organized answer.
Glycolysis Under Anaerobic Conditions
Glycolysis is a sequence of 10 cytosolic reactions that converts one molecule of glucose (6C) into two molecules of pyruvate (3C), generating ATP by substrate-level phosphorylation. Under anaerobic conditions, pyruvate cannot enter the mitochondria for oxidation; instead, it is reduced to lactate by lactate dehydrogenase (LDH), regenerating NAD+ so that glycolysis can continue.
Overall anaerobic equation:
Glucose + 2 ADP + 2 Pi → 2 Lactate + 2 ATP + 2 H₂O + 2 H⁺
The Two Phases
| Phase | Steps | Events |
|---|
| Energy Investment Phase | 1-5 | 2 ATP consumed; glucose is phosphorylated and cleaved into two triose phosphates |
| Energy Generation Phase | 6-10 | 4 ATP produced (net +2); NADH generated and re-oxidized to NAD⁺ via lactate |
The 10 Steps
Step 1 - Glucose → Glucose 6-phosphate (G6P)
- Enzyme: Hexokinase (most tissues) / Glucokinase (liver, pancreatic β-cells) -- Hexokinase IV
- Coenzyme/Cofactor: Mg²⁺ (for ATP-Mg²⁺ complex)
- ATP consumed: 1
- Notes: Irreversible. G6P traps glucose inside the cell. Hexokinase I-III are inhibited allosterically by G6P (product inhibition). Glucokinase (hexokinase IV) has a high Km and high Vmax -- it is not inhibited by G6P and acts as a glucose sensor in the liver.
Step 2 - Glucose 6-phosphate → Fructose 6-phosphate (F6P)
- Enzyme: Phosphoglucose isomerase (phosphohexose isomerase)
- Coenzyme: None
- Notes: Reversible aldose-ketose isomerization. Not a regulated step.
Step 3 - Fructose 6-phosphate → Fructose 1,6-bisphosphate (F1,6-BP)
- Enzyme: Phosphofructokinase-1 (PFK-1)
- Coenzyme/Cofactor: Mg²⁺
- ATP consumed: 1
- Notes: Rate-limiting, committed, irreversible step -- the most important regulatory point in glycolysis. PFK-1 is the "pacemaker" enzyme.
Step 4 - Fructose 1,6-bisphosphate → DHAP + Glyceraldehyde 3-phosphate (G3P)
- Enzyme: Aldolase
- Coenzyme: None
- Notes: Reversible aldol cleavage. Produces two triose phosphates: dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P).
Step 5 - DHAP → Glyceraldehyde 3-phosphate
- Enzyme: Triose phosphate isomerase (TPI)
- Coenzyme: None
- Notes: Reversible. DHAP is converted to G3P so it can continue in the pathway. From this step onward, all reactions occur twice per glucose (once for each G3P).
Step 6 - G3P → 1,3-Bisphosphoglycerate (1,3-BPG)
- Enzyme: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
- Coenzyme: NAD⁺ (reduced to NADH + H⁺); inorganic phosphate (Pi)
- Notes: Oxidative phosphorylation at substrate level. Produces one molecule of NADH per G3P (2 total per glucose). Under anaerobic conditions, this NADH must be re-oxidized to NAD⁺ (via LDH at step 11); otherwise glycolysis halts. Inhibited by iodoacetate (–SH poison). Arsenate competes with Pi and prevents ATP generation at this step.
Step 7 - 1,3-BPG → 3-Phosphoglycerate (3-PG) + ATP
- Enzyme: Phosphoglycerate kinase (PGK)
- Coenzyme/Cofactor: Mg²⁺
- ATP produced: 1 per G3P → 2 ATP per glucose (substrate-level phosphorylation)
- Notes: Physiologically reversible reaction. This step recovers the 2 ATP invested in steps 1 and 3. (Side note: some 1,3-BPG is diverted to 2,3-BPG in RBCs by bisphosphoglycerate mutase -- this is the Rapoport-Luebering shunt.)
Step 8 - 3-Phosphoglycerate → 2-Phosphoglycerate (2-PG)
- Enzyme: Phosphoglycerate mutase
- Coenzyme: Mg²⁺; requires 2,3-BPG as a cofactor
- Notes: Reversible intramolecular phosphate shift from C-3 to C-2.
Step 9 - 2-Phosphoglycerate → Phosphoenolpyruvate (PEP) + H₂O
- Enzyme: Enolase
- Coenzyme/Cofactor: Mg²⁺ or Mn²⁺ (required)
- Notes: Reversible dehydration. Creates PEP, a high-energy phosphate compound. Inhibited by fluoride (fluoride-oxalate used in blood collection tubes to prevent glycolysis and preserve glucose levels for lab measurement).
Step 10 - PEP → Pyruvate + ATP
- Enzyme: Pyruvate kinase (PK)
- Coenzyme/Cofactor: Mg²⁺, K⁺
- ATP produced: 1 per G3P → 2 ATP per glucose (substrate-level phosphorylation)
- Notes: Irreversible under physiological conditions (large -ΔG). The immediate product enolpyruvate spontaneously isomerizes to pyruvate, making reversal impossible. Isozymes: L (liver), R (RBC), M1 (muscle/brain), M2 (fetal tissues, tumors).
Step 11 (Anaerobic-specific) - Pyruvate → Lactate
- Enzyme: Lactate dehydrogenase (LDH)
- Coenzyme: NADH (oxidized to NAD⁺)
- Notes: This step is unique to anaerobic glycolysis. NADH produced in step 6 is re-oxidized here, regenerating NAD⁺ to sustain glycolysis. No ATP is produced or consumed. LDH reaction is readily reversible -- in well-oxygenated tissues (liver, heart), lactate is oxidized back to pyruvate.
Summary of Enzymes and Coenzymes
| Step | Enzyme | Coenzyme/Cofactor | Reversibility |
|---|
| 1 | Hexokinase / Glucokinase | Mg²⁺, ATP | Irreversible |
| 2 | Phosphoglucose isomerase | - | Reversible |
| 3 | PFK-1 | Mg²⁺, ATP | Irreversible |
| 4 | Aldolase | - | Reversible |
| 5 | Triose phosphate isomerase | - | Reversible |
| 6 | GAPDH | NAD⁺, Pi | Reversible |
| 7 | Phosphoglycerate kinase | Mg²⁺, ADP | Reversible |
| 8 | Phosphoglycerate mutase | Mg²⁺, 2,3-BPG | Reversible |
| 9 | Enolase | Mg²⁺ / Mn²⁺ | Reversible |
| 10 | Pyruvate kinase | Mg²⁺, K⁺, ADP | Irreversible |
| 11* | Lactate dehydrogenase | NADH | Reversible |
*Step 11 is the anaerobic-specific terminal reaction.
Energetics
ATP Balance
| Event | ATP Change |
|---|
| Step 1 (Hexokinase) | -1 ATP |
| Step 3 (PFK-1) | -1 ATP |
| Step 7 (PGK) x 2 | +2 ATP |
| Step 10 (Pyruvate kinase) x 2 | +2 ATP |
| Net ATP yield | +2 ATP per glucose |
NADH Balance (Anaerobic)
- Step 6 produces 2 NADH per glucose
- Step 11 (LDH) consumes 2 NADH (re-oxidizes them to NAD⁺)
- Net NADH = 0 (no net production or consumption)
Comparison: Aerobic vs Anaerobic
| Condition | ATP yield per glucose |
|---|
| Anaerobic glycolysis | 2 ATP |
| Aerobic glycolysis (to pyruvate only) | 2 ATP + 2 NADH |
| Complete aerobic oxidation (glucose → CO₂ + H₂O) | ~30-32 ATP |
Because anaerobic glycolysis yields only 2 ATP vs ~32 ATP from aerobic oxidation, cells must run glycolysis ~15 times faster under anaerobic conditions to produce the same amount of ATP. They compensate by expressing very high levels of glycolytic enzymes.
Free Energy
The overall reaction (glucose → 2 lactate) has a large negative ΔG, meaning it is thermodynamically favorable and essentially irreversible as a whole, despite individual steps being reversible.
Regulation of Glycolysis
Regulation is focused on the three irreversible enzymes (hexokinase/glucokinase, PFK-1, pyruvate kinase). These are controlled at three levels: allosteric, covalent modification, and transcriptional (hormonal).
1. Hexokinase / Glucokinase (Step 1)
| Feature | Hexokinase I-III | Glucokinase (HK IV) |
|---|
| Km for glucose | Low (~0.1 mM) -- high affinity | High (~10 mM) -- low affinity |
| Vmax | Low | High |
| Inhibition | Allosterically by G6P (product inhibition) | Not inhibited by G6P |
| Tissue | Most tissues | Liver, pancreatic β-cells |
| Regulation | G6P accumulates → hexokinase off | Regulated by GKRP (glucokinase regulatory protein) in nucleus; fructose-6-P sequesters GK into nucleus (inactive); glucose releases it |
| Role | Efficient trapping at low glucose | Glucose sensor; handles glucose floods post-meal |
2. PFK-1 (Step 3) -- The Master Regulator
Inhibitors:
- ATP (high energy signal - binds allosteric site, decreases affinity for F6P)
- Citrate (signals TCA intermediates are abundant; also inhibits)
- H⁺ / acidosis (protects against excessive lactate acidosis)
- Long-chain fatty acyl CoA
Activators:
- AMP / ADP (low energy signal -- most powerful physiological activator)
- Fructose 2,6-bisphosphate (F-2,6-BP) -- most potent activator
- Pi (inorganic phosphate)
Fructose 2,6-bisphosphate (F-2,6-BP) regulation:
- Produced by PFK-2 from fructose 6-phosphate
- PFK-2 is a bifunctional enzyme: has both kinase and phosphatase activity
- In the fed state: insulin activates PFK-2 (kinase domain) → F-2,6-BP rises → PFK-1 activated → glycolysis stimulated
- In the fasted state: glucagon → PKA → phosphorylates PFK-2 (inactivates kinase, activates phosphatase) → F-2,6-BP falls → PFK-1 inhibited → glycolysis slows
- F-2,6-BP also inhibits fructose 1,6-bisphosphatase (gluconeogenesis), ensuring the two pathways don't run simultaneously (preventing a futile cycle)
3. Pyruvate Kinase (Step 10)
Inhibitors (allosteric):
- ATP
- Acetyl-CoA
- Alanine (L isozyme in liver -- feed-forward inhibition if amino acids are abundant)
- Long-chain fatty acids
Activators (allosteric):
- Fructose 1,6-bisphosphate (F-1,6-BP) -- feed-forward activation (product of PFK-1 activates PK downstream)
- AMP
Covalent regulation (L isozyme, liver only):
- Glucagon → cAMP → PKA → phosphorylates PK → inhibits PK → prevents futile cycling with gluconeogenesis
- Insulin → dephosphorylation → activates PK
- M1 isozyme (muscle/brain) is NOT regulated by covalent modification
4. Hormonal (Transcriptional) Regulation
| Hormone | Effect on Glycolytic Enzymes | Enzymes Affected |
|---|
| Insulin (fed state) | Increases gene transcription (+10-20 fold over hours-days) | Glucokinase, PFK-1, Pyruvate kinase (liver) |
| Glucagon/Epinephrine (fasted/stress) | Decreases gene transcription; also activates PKA for covalent inhibition | Same three enzymes |
Transcription factors involved: SREBP-1c (insulin-mediated) and ChREBP (carbohydrate/glucose-mediated).
Tissues Dependent on Anaerobic Glycolysis
| Tissue | Reason |
|---|
| Red blood cells | No mitochondria |
| Lens and cornea of eye | Poorly vascularized, avascular |
| Renal medulla | Relatively low oxygen tension |
| Exercising skeletal muscle (fast-twitch) | O₂ delivery lags demand; high glycolytic enzyme content |
| Tumors | Warburg effect -- preferentially use glycolysis even in oxygen |
| White matter of brain | Under hypoxic conditions |
Key Clinical Points
- Lactic acidosis: Collapse of circulation (MI, shock, sepsis) → impaired O₂ delivery → cells rely entirely on anaerobic glycolysis → lactate accumulates → metabolic acidosis. Blood lactate measurement allows rapid detection of O₂ debt.
- Muscle cramps during exercise: NADH accumulation and H⁺ production from lactate.
- Fluoride-oxalate blood tubes: Fluoride inhibits enolase (step 9), preventing glycolysis in blood samples collected for glucose measurement.
- Arsenic poisoning: Arsenate competes with Pi at GAPDH (step 6), bypassing 1,3-BPG formation, thus preventing ATP synthesis by glycolysis.
- Thiamine deficiency (Wernicke's encephalopathy, alcoholism): Impairs pyruvate dehydrogenase (requires TPP), causing pyruvate accumulation and lactic acidosis -- technically affects the step after glycolysis, but functionally blocks glucose metabolism.
Sources: Biochemistry, 8th ed. Lippincott Illustrated Reviews (pp. 293-321); Harper's Illustrated Biochemistry, 32nd ed. (pp. 175-180); Basic Medical Biochemistry: A Clinical Approach, 6th ed. (pp. 803-805)